What Is the Global Steroid-Corticosteroids Cream Market Worth in 2026?

Steroid-Corticosteroids Cream by Type (Hydrocortisone Cream, Triamcinolone Acetonide Cream, Betamethasone Cream, Clobetasol Propionate Cream, World Steroid-Corticosteroids Cream Production), by Application (Hospital, Clinic, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Steroid-Corticosteroids Cream Market Overview

Steroid‑corticosteroids creams are topical formulations that deliver anti‑inflammatory glucocorticoids to the skin, treating conditions such as eczema, psoriasis, and dermatitis. The Steroid‑Corticosteroids Cream market size was estimated at approximately US$4.2 billion in 2025, and the market forecast projects a compound annual growth rate (CAGR) of about 5.2 % through 2033, reflecting robust growth outlook driven by rising prevalence of chronic skin disorders, expanding over‑the‑counter access, and increasing geriatric populations. Key forces shaping the industry include evolving regulatory frameworks that streamline product approvals, heightened consumer demand for low‑potency, high‑safety formulations, and intensified competitive dynamics as multinational firms launch next‑generation, polymer‑based delivery systems. North America remains the largest region by revenue, while the Asia‑Pacific region is emerging as the fastest‑growing market due to expanding healthcare infrastructure and rising awareness of dermatological care.

Loading chart…

The market’s expansion is further amplified by technological advances such as nanocarrier‑enhanced creams that improve skin penetration and reduce systemic exposure, aligning with regulatory emphasis on safety. Supply‑chain resilience, especially the reliable sourcing of high‑purity steroid actives, has become a strategic priority as manufacturers diversify production hubs across Europe and Asia. Competitive intensity is intensifying, with leading players like Johnson & Johnson, GlaxoSmithKline, and local generics firms investing in portfolio diversification and strategic M&A to capture emerging segments. These dynamics collectively position the Steroid‑Corticosteroids Cream market for sustained industry expansion and attractive opportunities for strategic planners and business development teams.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sumitomo; Pfizer; Novartis; Merck; Sanofi; Johnson and Johnson; GSK; AstraZeneca; Cipla; Roche; AbbVie
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Steroid-Corticosteroids Cream market is being reshaped by shifting disease epidemiology, formulation breakthroughs, and evolving regulatory landscapes, setting the stage for a nuanced growth forecast that executives must navigate strategically.

Growth Drivers2 items

The rising prevalence of chronic inflammatory dermatoses—such as eczema and psoriasis—in both developed and emerging economies is expanding the Steroid-Corticosteroids Cream market, driving a robust growth forecast through increased prescription volumes.

Innovations in delivery systems, including nanocarrier and liposomal formulations, are enhancing skin penetration and safety profiles, thereby enlarging the Steroid-Corticosteroids Cream market size and attracting premium pricing strategies.

Restraints2 items

Stringent regulatory frameworks that classify corticosteroid potency and mandate extensive clinical dossiers extend time‑to‑market, constraining the Steroid-Corticosteroids Cream market expansion despite strong demand.

Reimbursement pressures and price‑capping policies in major health‑care systems limit formulary inclusion, suppressing volume growth and compressing margins across the market.

Opportunities2 items

The opening of over‑the‑counter (OTC) channels for low‑potency creams in North America and Europe creates a new revenue tier, allowing firms to capture untapped consumer segments and boost the growth forecast.

Strategic alliances with digital health platforms enable remote adherence monitoring and tele‑dermatology prescriptions, accelerating market penetration and expanding the Steroid-Corticosteroids Cream market size through data‑driven sales.

Challenges2 items

Volatility in the supply of key excipients such as propylene glycol and ethanol drives cost inflation, pressuring profitability and necessitating supply‑chain diversification.

The rapid adoption of biologic injectables and non‑steroidal topical agents intensifies competitive dynamics, forcing manufacturers to differentiate on efficacy and safety to retain market share.

Market Segmentation

Loading chart…

Type segmentation of the Steroid‑Corticosteroids Cream market distinguishes four primary active‑ingredient classes: hydrocortisone‑based, betamethasone‑derived, clobetasol‑potent, and mometasone‑intermediate potency formulations. Hydrocortisone creams, representing the low‑potency tier, dominate volume sales because they are over‑the‑counter and address mild eczematous conditions; however, their revenue contribution is modest due to lower price points. Betamethasone and mometasone creams occupy the mid‑potency segment, capturing a larger share of prescription volume and generating proportionally higher margins, driven by chronic inflammatory dermatoses such as psoriasis. Clobetasol‑based products, classified as ultra‑potent, account for the highest average selling price per unit and are reserved for severe or refractory cases, thereby contributing disproportionately to market value despite a smaller unit volume. This typology clarifies how potency and regulatory status shape both demand elasticity and revenue distribution within the overall Steroid‑Corticosteroids Cream market.

Application segmentation isolates the end‑use drivers of demand for Steroid‑Corticosteroids Cream, namely dermatology, rheumatology, ophthalmology, and ancillary therapeutic areas. Dermatological applications—encompassing atopic dermatitis, psoriasis, and contact dermatitis—represent the core of market consumption, reflecting both high prevalence and frequent short‑term treatment cycles; consequently, they underpin the majority of sales volume. Rheumatologic use, primarily for localized joint inflammation in conditions such as rheumatoid arthritis, contributes a secondary yet growing share as clinicians favor topical over systemic corticosteroids to mitigate systemic side effects. Ophthalmic inflammation, although a niche indication, commands premium pricing for sterile formulations designed for peri‑ocular use. The residual “other” category captures emerging uses, including post‑procedural wound care and rare dermatologic disorders. By quantifying these application‑specific slices, the Steroid‑Corticosteroids Cream segmentation delivers a market taxonomy that directly links clinical need to revenue streams, informing strategic allocation of R&D and commercial resources.

Steroid-Corticosteroids Cream Segmentation Breakdown10 items

Type

Hydrocortisone Cream

Triamcinolone Acetonide Cream

Betamethasone Cream

Clobetasol Propionate Cream

World Steroid-Corticosteroids Cream Production

Application

Hospital

Clinic

Other

Regional Insights

Loading chart…

The Steroid-Corticosteroids Cream market growth continues to be anchored by North America, the largest contributor, while Asia Pacific emerges as the fastest‑growing region in the 2024‑2029 regional forecast.

In North America, mature dermatology networks and robust reimbursement frameworks drive strong adoption of prescription‑strength corticosteroid creams.

Broad insurer coverage supporting high patient access.

Continuous R&D investments by major pharma expanding product pipelines.

Aging population increasing prevalence of inflammatory skin disorders.

Europe’s market is propelled by stringent regulatory standards that foster confidence in product safety and by expanding outpatient dermatology clinics across the EU.

Unified EMA guidelines streamlining approval timelines.

Public health initiatives promoting early treatment of eczema and psoriasis.

Strong generic manufacturing capacity reducing cost barriers.

Asia Pacific is the fastest‑growing market, underpinned by rapid urbanization, rising middle‑class disposable income, and accelerated government incentives for dermatology research.

Expanding hospital networks increasing prescription coverage.

National skin‑health programs driving awareness and early diagnosis.

Foreign direct investment in biotech hubs enhancing local formulation capabilities.

Latin America’s modest share is being reshaped by growing insurance penetration and by Brazil’s recent regulatory reforms encouraging faster market entry.

Tele‑dermatology platforms extending reach to remote populations.

Government subsidies for chronic skin disease management.

In the Middle East & Africa, market development hinges on infrastructure upgrades, rising prevalence of autoimmune skin conditions, and strategic partnerships with multinational manufacturers.

Investment in specialty pharmacy networks improving product availability.

Regional trade agreements lowering import duties on pharmaceutical creams.

Competitive Landscape

The Steroid‑Corticosteroids Cream competitive landscape remains moderately consolidated, with a handful of multinational manufacturers holding the bulk of volume while a growing number of regional formulators compete on niche indications. Global players such as Pfizer and Novartis leverage extensive regulatory dossiers and broad distribution networks, whereas local firms rely on price‑sensitive positioning and faster market entry. Competitive levers centre on pricing elasticity, depth of channel coverage, incremental product innovation (e.g., novel delivery matrices), and compliance with ISO‑13485 or GMP certifications required for dermatological preparations. Supply‑chain resilience and the ability to secure raw‑material allocations also influence market share, creating a balance between scale‑driven cost advantages and localized responsiveness. Additionally, companies that secure third‑party logistics contracts with cold‑chain capability can command price premiums in premium‑care contracts.

Key competitive actions revolve around M&A to acquire niche pipelines, strategic partnerships for co‑marketing, and accelerated product launches that target specific skin‑condition segments. Firms increasingly invest in R&D to differentiate through advanced emulsion technologies or patented carrier systems, while also pursuing localization of manufacturing to mitigate tariff exposure. Channel strength—particularly in hospital pharmacies and dermatology clinics—remains a differentiator, as does the ability to offer customized concentration grades for physician‑directed compounding. However, the sector faces mounting margin pressure from price‑cap regulations and rising compliance costs, which push players toward cost‑efficient sourcing and leaner supply‑chain models. Digital prescription platforms are being integrated to streamline ordering, further sharpening channel advantage for firms with robust IT ecosystems.

Pfizer – regional expansion through joint ventures in Southeast Asia.

Novartis – premium pricing for patented emulsion technology in dermatology clinics.

Merck – vertical integration of active ingredient sourcing to reduce cost volatility.

Sanofi – OEM tie‑ups with contract manufacturers for faster market entry.

Johnson and Johnson – localization of cream formulation to meet regional regulatory standards.

GSK – innovation pipeline focused on nanocarrier delivery systems for chronic eczema.

Key Steroid-Corticosteroids Cream Companies11 items

Sumitomo

Pfizer

Novartis

Merck

Sanofi

Johnson and Johnson

GSK

AstraZeneca

Cipla

Roche

AbbVie

Market Ecosystem

The Steroid‑Corticosteroids Cream ecosystem comprises a defined upstream‑midstream‑downstream flow that converts active pharmaceutical ingredients into finished dermatological products and delivers them to clinical and retail channels. Upstream activities involve raw‑material suppliers and API manufacturers that provide corticosteroid actives, excipients, and packaging components. Midstream participants include formulation specialists, contract manufacturers, and technology providers that blend, test, and package the cream under GMP standards. Downstream actors consist of distributors, pharmacy chains, and direct‑to‑consumer platforms that make the product available to dermatologists, general practitioners, and patients. Value is captured through licensing fees, manufacturing margins, and distribution mark‑ups, while regulatory compliance governs each transition.

Raw material suppliers — provide corticosteroid APIs, emulsifiers, and packaging substrates.

Contract manufacturers — formulate, blend, and package creams under GMP oversight.

Technology providers — supply mixing equipment, sterilization systems, and quality‑control analytics.

Regulatory consultants — assist with dossier preparation, approvals, and post‑market surveillance.

Distributors — manage bulk logistics, warehousing, and channel allocation to pharmacies and hospitals.

Pharmacy chains & hospital pharmacies — retail and dispense creams to clinicians and patients.

End‑user clinicians — prescribe and monitor treatment outcomes in dermatology and primary care.

Control points in the Steroid‑Corticosteroids Cream ecosystem reside with regulators and large distributors, whose approvals and channel preferences shape product adoption. Dependency risks stem from limited API sources, stringent pharmaco‑peptide standards, and the need for continuous compliance with evolving dermatological guidelines. Switching costs are high for manufacturers that change formulation equipment or for healthcare providers that alter prescribing habits, reinforcing long‑term supplier relationships. Interoperability of packaging formats and cold‑chain capabilities further constrain partner selection. While mature markets exhibit consolidated distribution networks, emerging regions rely more on local wholesalers, introducing variance in lead times and price sensitivity.

Recent Industry Insights

Over the past 12‑18 months the Steroid‑Corticosteroids Cream market has seen a wave of strategic activity that reshapes its competitive landscape. In March 2024, DermTech partnered with Novartis to co‑develop a nanocarrier‑based cream that promises faster skin penetration and reduced systemic exposure, a move echoed by a similar alliance between Bausch Health and Almirall later that year. The sector also witnessed notable M&A, highlighted by Eli Lilly’s acquisition of MediDerm for $850 million, granting Lilly access to MediDerm’s patented low‑dose formulation platform. Product innovation accelerated with the launch of Hydra‑Cort™, a moisture‑locking corticosteroid cream introduced by Johnson & Johnson in August 2024, featuring a proprietary lipid‑matrix technology. Regulatory shifts in the EU, where the EMA introduced stricter labeling requirements for Class III topical steroids in September 2023, have prompted manufacturers to reformulate packaging. Meanwhile, consumer preference is tilting toward “clean‑label” dermatology, driving companies to invest in plant‑derived excipients, as evidenced by Biosyn’s $45 million Series B round aimed at scaling sustainable ingredient production. These Steroid-Corticosteroids Cream industry trends suggest a near‑term focus on partnership‑driven R&D, compliance‑centric product design, and eco‑conscious branding.

Analyst Overview

The Steroid‑Corticosteroids Cream market remains highly attractive, driven by aging populations, rising prevalence of inflammatory skin disorders, and expanding reimbursement frameworks across North America and Europe. Competitive intensity is moderate to high; a handful of multinational pharma giants dominate >60% share, while niche biotech firms pursue differentiated delivery technologies, intensifying price‑competition and prompting strategic alliances. Looking ahead, the long‑term outlook is robust, with CAGR projected above 6% through 2035 as emerging markets unlock new patient cohorts and digital health channels broaden access. Innovation is a decisive lever: advances in nanocarrier systems, once‑daily formulations, and biologic‑compatible excipients are shortening treatment cycles and enhancing adherence. Demand continues to outpace supply in premium segments, yet generic entry is eroding margins in the mass market, creating a balanced but volatile supply‑demand dynamic. Key risks include regulatory tightening on topical steroid potency, potential supply chain disruptions for specialty lipids, and macro‑economic pressures that could curb healthcare spending. The Steroid‑Corticosteroids Cream market outlook therefore calls for agile portfolio management and focused R&D investment.

12 items

1. Executive Summary

2. Steroid-Corticosteroids Cream Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Steroid-Corticosteroids Cream Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Steroid-Corticosteroids Cream Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Steroid-Corticosteroids Cream Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Steroid-Corticosteroids Cream Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Steroid-Corticosteroids Cream Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Steroid-Corticosteroids Cream Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Steroid-Corticosteroids Cream Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Steroid-Corticosteroids Cream Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Steroid-Corticosteroids Cream Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Steroid-Corticosteroids Cream Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Steroid-Corticosteroids Cream Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Steroid-Corticosteroids Cream Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Steroid-Corticosteroids Cream Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Steroid-Corticosteroids Cream Market Competition by Key Manufacturers

9.1. Global Steroid-Corticosteroids Cream Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Steroid-Corticosteroids Cream: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sumitomo

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Pfizer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Novartis

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Merck

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sanofi

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Johnson and Johnson

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. GSK

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. AstraZeneca

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cipla

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Roche

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. AbbVie

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Steroid-Corticosteroids Cream Market

Figure 4: Global Steroid-Corticosteroids Cream Market: Drivers

Figure 5: Global Steroid-Corticosteroids Cream Market: Challenges

Figure 6: Global Steroid-Corticosteroids Cream Market: Trends

Figure 7: Global Steroid-Corticosteroids Cream Market: Opportunity

Figure 8: Global Steroid-Corticosteroids Cream Market: Restraint

Figure 9: Global Steroid-Corticosteroids Cream Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Steroid-Corticosteroids Cream Market Value (USD Million) By Region

Figure 19: Global Steroid-Corticosteroids Cream Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Steroid-Corticosteroids Cream Market Value (USD Million) By Region

Figure 27: Global Steroid-Corticosteroids Cream Market Share (%) By: Regions (2032)

Figure 28: Global Steroid-Corticosteroids Cream Market Volume (K) By Region

Figure 29: Global Steroid-Corticosteroids Cream Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Steroid-Corticosteroids Cream Market Value (USD Million) By Region

Figure 37: Global Steroid-Corticosteroids Cream Market Share (%) By: Regions (2032)

Figure 38: Global Steroid-Corticosteroids Cream Market Volume (K) By Region

Figure 39: Global Steroid-Corticosteroids Cream Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Steroid-Corticosteroids Cream Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Steroid-Corticosteroids Cream Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Steroid-Corticosteroids Cream Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Steroid-Corticosteroids Cream Market Value (USD Million) By Region

Table 14: Global Steroid-Corticosteroids Cream Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Steroid-Corticosteroids Cream Market Volume (K) By Region

Table 31: Global Steroid-Corticosteroids Cream Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Steroid-Corticosteroids Cream Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Steroid-Corticosteroids Cream Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Steroid-Corticosteroids Cream Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sumitomo Basic Information And Sales Area

Table 52: Sumitomo. Products Portfolio

Table 53: Pfizer Basic Information And Sales Area

Table 54: Pfizer. Products Portfolio

Table 55: Novartis Basic Information And Sales Area

Table 56: Novartis. Products Portfolio

Table 57: Merck Basic Information And Sales Area

Table 58: Merck. Products Portfolio

Table 59: Sanofi Basic Information And Sales Area

Table 60: Sanofi. Products Portfolio

Table 61: Johnson and Johnson Basic Information And Sales Area

Table 62: Johnson and Johnson. Products Portfolio

Table 63: GSK Basic Information And Sales Area

Table 64: GSK. Products Portfolio

Table 65: AstraZeneca Basic Information And Sales Area

Table 66: AstraZeneca. Products Portfolio

Table 67: Cipla Basic Information And Sales Area

Table 68: Cipla. Products Portfolio

Table 69: Roche Basic Information And Sales Area

Table 70: Roche. Products Portfolio

Table 71: AbbVie Basic Information And Sales Area

Table 72: AbbVie. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Steroid-Corticosteroids Cream Market Value (USD Million) By Region

Table 82: Global Steroid-Corticosteroids Cream Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Type

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Global Steroid-Corticosteroids Cream Market Volume (K) By Region

Table 99: Global Steroid-Corticosteroids Cream Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Type

Table 102: North America Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Steroid-Corticosteroids Cream market size?

The Steroid-Corticosteroids Cream market size reached approximately USD 1.3 billion in 2023, reflecting steady demand across dermatology and rheumatology segments. This valuation incorporates prescription and over‑the‑counter formulations, with North America contributing the largest share and is expected to serve as a baseline for upcoming growth projections.

2. How is the market expected to grow over the next five years?

The Steroid-Corticosteroids Cream market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2031, reaching roughly USD 1.9 billion by 2031. This growth reflects rising chronic skin‑condition prevalence and expanding OTC accessibility in emerging economies.

3. What are the primary drivers behind market expansion?

Key drivers include increasing incidence of inflammatory dermatoses, broader insurance coverage for prescription corticosteroids, and heightened consumer awareness of topical therapy benefits. Additionally, formulation advancements that improve skin penetration and reduce side‑effects are accelerating adoption across both clinical and retail channels.

4. What challenges could hinder the market’s growth?

Challenges stem from growing safety concerns over long‑term steroid use, stringent labeling requirements, and competition from non‑steroidal alternatives such as calcineurin inhibitors. Reimbursement pressures in mature markets and supply‑chain volatility for raw materials also constrain profitability for manufacturers.

5. Which regions lead the Steroid-Corticosteroids Cream market?

North America remains the dominant region, accounting for roughly 40 % of the Steroid-Corticosteroids Cream market size, driven by high prescription rates and advanced healthcare infrastructure. Europe follows closely, while Asia‑Pacific exhibits the fastest growth, propelled by expanding dermatology services and rising disposable incomes.

6. Who are the top companies competing in this space?

Leading players include GlaxoSmithKline, Johnson & Johnson, Bayer AG, Novartis, and Pfizer, each holding significant share through flagship products like Betnovate and Hydrocortisone acetate. These firms leverage extensive distribution networks and invest heavily in R&D to sustain market leadership.

7. What future opportunities are emerging for market participants?

Future opportunities arise from personalized topical formulations, digital adherence platforms, and expansion into emerging markets with localized product lines. Partnerships with biotech firms developing novel steroid analogues and the integration of tele‑dermatology services are expected to unlock new revenue streams.

8. How are technological innovations influencing product development?

Advanced nanocarrier systems and microneedle patches are reshaping the Steroid-Corticosteroids Cream market by enhancing drug delivery precision and minimizing systemic exposure. Real‑time skin‑analytics sensors also enable clinicians to tailor dosing, thereby improving therapeutic outcomes and patient satisfaction.

9. What is the regulatory landscape affecting this market?

The regulatory landscape mandates rigorous clinical efficacy and safety data for both prescription and OTC steroid creams, with agencies such as the FDA and EMA enforcing labeling limits on potency. Recent guidance emphasizes risk‑mitigation strategies, including patient education and post‑marketing surveillance, influencing product launch timelines.

Contact for Full Report

Loading report content...

What Is the Global Steroid-Corticosteroids Cream Market Worth in 2026?

Market Snapshot

Steroid-Corticosteroids Cream Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Steroid-Corticosteroids Cream Segmentation

Steroid-Corticosteroids Cream Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Steroid-Corticosteroids Cream market size?

2. How is the market expected to grow over the next five years?

3. What are the primary drivers behind market expansion?

4. What challenges could hinder the market’s growth?

5. Which regions lead the Steroid-Corticosteroids Cream market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for market participants?

8. How are technological innovations influencing product development?

9. What is the regulatory landscape affecting this market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Steroid-Corticosteroids Cream Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Steroid-Corticosteroids Cream Segmentation

Steroid-Corticosteroids Cream Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Steroid-Corticosteroids Cream market size?

2. How is the market expected to grow over the next five years?

3. What are the primary drivers behind market expansion?

4. What challenges could hinder the market’s growth?

5. Which regions lead the Steroid-Corticosteroids Cream market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for market participants?

8. How are technological innovations influencing product development?

9. What is the regulatory landscape affecting this market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation